APEIRON Biologics

    OverviewSuggest Edit

    APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. Its product APN311 is an autologous cellular therapy to enhance immune reactivity via an intracellular immune master checkpoint. APEIRON's solution is developed for the treatment of pediatric neuroblastoma patients.
    TypePrivate
    Founded2005
    HQWien, AT
    Websiteapeiron-biologics.com

    Latest Updates

    Employees (est.) (Oct 2021)34
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at APEIRON Biologics

    Peter Llewellyn-Davies

    Peter Llewellyn-Davies

    Chief Executive Officer, Chief Financial Officer
    Andreas Stadler

    Andreas Stadler

    Director Finance
    Romana Gugenberger

    Romana Gugenberger

    Chief Medical & Scientific Officer (CMSO)
    Andreas Gerber

    Andreas Gerber

    Chief Operating Officer (COO)
    Manfred Reichl

    Manfred Reichl

    Chairman
    Show more

    APEIRON Biologics Office Locations

    APEIRON Biologics has an office in Wien
    Wien, AT (HQ)
    Campus-Vienna-Biocenter 5
    Show all (1)

    APEIRON Biologics Financials and Metrics

    Summary Metrics

    Founding Date

    2005

    APEIRON Biologics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    96/100

    SecurityScorecard logo

    APEIRON Biologics Online and Social Media Presence

    Embed Graph

    APEIRON Biologics News and Updates

    APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

    VIENNA and GAITHERSBURG, Md., July 8, 2020 /PRNewswire/ -- APEIRON Biologics AG ("APEIRON"), a private biotechnology company specializing in the discovery, development and commercialization of novel immunotherapies for cancer and respiratory diseases, and MaxCyte, Inc., a global...

    APEIRON Biologics Frequently Asked Questions

    • When was APEIRON Biologics founded?

      APEIRON Biologics was founded in 2005.

    • Who are APEIRON Biologics key executives?

      APEIRON Biologics's key executives are Peter Llewellyn-Davies, Andreas Stadler and Romana Gugenberger.

    • How many employees does APEIRON Biologics have?

      APEIRON Biologics has 34 employees.

    • Who are APEIRON Biologics competitors?

      Competitors of APEIRON Biologics include Enara Bio, Scorpion Therapeutics and Aeglea.

    • Where is APEIRON Biologics headquarters?

      APEIRON Biologics headquarters is located at Campus-Vienna-Biocenter 5, Wien.

    • Where are APEIRON Biologics offices?

      APEIRON Biologics has an office in Wien.

    • How many offices does APEIRON Biologics have?

      APEIRON Biologics has 1 office.